Psilocybin-induced Spiritual Experiences and Insightfulness Are Associated with Synchronization of Neuronal Oscillations
Overview
Affiliations
Rationale: During the last years, considerable progress has been made toward understanding the neuronal basis of consciousness by using sophisticated behavioral tasks, brain-imaging techniques, and various psychoactive drugs. Nevertheless, the neuronal mechanisms underlying some of the most intriguing states of consciousness, including spiritual experiences, remain unknown.
Objectives: To elucidate state of consciousness-related neuronal mechanisms, human subjects were given psilocybin, a naturally occurring serotonergic agonist and hallucinogen that has been used for centuries to induce spiritual experiences in religious and medical rituals.
Methods: In this double-blind, placebo-controlled study, 50 healthy human volunteers received a moderate dose of psilocybin, while high-density electroencephalogram (EEG) recordings were taken during eyes-open and eyes-closed resting states. The current source density and the lagged phase synchronization of neuronal oscillations across distributed brain regions were computed and correlated with psilocybin-induced altered states of consciousness.
Results: Psilocybin decreased the current source density of neuronal oscillations at 1.5-20 Hz within a neural network comprising the anterior and posterior cingulate cortices and the parahippocampal regions. Most intriguingly, the intensity levels of psilocybin-induced spiritual experience and insightfulness correlated with the lagged phase synchronization of delta oscillations (1.5-4 Hz) between the retrosplenial cortex, the parahippocampus, and the lateral orbitofrontal area.
Conclusions: These results provide systematic evidence for the direct association of a specific spatiotemporal neuronal mechanism with spiritual experiences and enhanced insight into life and existence. The identified mechanism may constitute a pathway for modulating mental health, as spiritual experiences can promote sustained well-being and psychological resilience.
Koning E, Chaves C, Kirkpatrick R, Brietzke E J Eat Disord. 2024; 12(1):214.
PMID: 39731144 PMC: 11673730. DOI: 10.1186/s40337-024-01185-8.
Impact of psilocybin on cognitive function: A systematic review.
Meshkat S, Tello-Gerez T, Gholaminezhad F, Dunkley B, Reichelt A, Erritzoe D Psychiatry Clin Neurosci. 2024; 78(12):744-764.
PMID: 39354706 PMC: 11612538. DOI: 10.1111/pcn.13741.
Nicholas C, Banks M, Lennertz R, Wenthur C, Krause B, Riedner B Transl Psychiatry. 2024; 14(1):372.
PMID: 39266503 PMC: 11393325. DOI: 10.1038/s41398-024-03059-8.
A Computational Account of the Development and Evolution of Psychotic Symptoms.
Powers A, Angelos P, Bond A, Farina E, Fredericks C, Gandhi J Biol Psychiatry. 2024; 97(2):117-127.
PMID: 39260466 PMC: 11634669. DOI: 10.1016/j.biopsych.2024.08.026.
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.
Ruffell S, Crosland-Wood M, Palmer R, Netzband N, Tsang W, Weiss B PCN Rep. 2024; 2(4):e146.
PMID: 38868739 PMC: 11114307. DOI: 10.1002/pcn5.146.